Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2019

01-04-2019 | Original article

Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers

Authors: Halil İbrahim Erdoğdu, Eray Atalay, Gül Gürsoy, Başol Canbakan, Serkan Aktürk, Canan Yazıcı, Orhan Yücel, Sinan Mersin, Sengül Üçer, Özgür Merhametsiz, Can Öner, Merve Erat

Published in: Clinical and Experimental Nephrology | Issue 4/2019

Login to get access

Abstract

Background

In hemodialysis patients Hepatitis B virus (HBV) infection is one of the problems. Because of HBV vaccine response is lower than in the general population, in this study it is aimed to determine the factors that may cause inadequate HBV vaccine response in hemodialysis patients.

Methods

In study, HBsAg, anti-HBs, anti-HBc IgG data belonging to 278 patients were obtained from file and computer records. It was seen that seronegative cases had been given recombinant HBV vaccine. Anti-HBs titers were monitored 1 month after vaccination was completed. According to this, the patients are divided into two groups. Those with anti-HBs < 10 IU/mL were identified as non-responders and with anti-HBs ≥ 10 IU/mL as responders. Factors such as age, serum albumin and urea reduction rate which may affect inadequate response to HBV vaccine were evaluated. As statistical examination, Chi-square test was used for the analysis of the data determined by counting, and logistic regression was used for statistically significant independent variables in chi-square test. p value of < 0.05 was considered statistically significant (Confidence interval: 95%).

Results

Out of 278 patients, according to exclusion criteria 81 patients were excluded. 13.2%(26/197) of HBV vaccinated patients had insufficient response. The inadequate response rate to HBV vaccination was found to be higher in patients with age ≥ 65 (p = 0.039), serum albumin < 3.5 g/dL (p = 0.024) and urea reduction rate ≤ 65 (p = 0.028). No statistically significant relationship was found between inadequate response to HBV vaccine and anti-HCV positivity, presence of diabetes mellitus, anemia status, vitamin D therapy and vascular access pathway variability.

Conclusion

We conclude that relatively high patient age, low albumin level and insufficient urea reduction rate may cause inadequate HBV vaccine response. Taking these factors into consideration may provide a useful insight for an adequate response to vaccination.
Literature
2.
go back to reference Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–55.CrossRefPubMed Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–55.CrossRefPubMed
3.
go back to reference Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593–608.CrossRefPubMed Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593–608.CrossRefPubMed
4.
go back to reference Toy M, Onder FO, Wörmann T, et al. Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infec Dis. 2011;11:337–46.CrossRef Toy M, Onder FO, Wörmann T, et al. Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infec Dis. 2011;11:337–46.CrossRef
5.
go back to reference Alter MJ, Arduino MJ, Lyerla HC, et al. Recommendations for preventing transmission of infections among chronic hemodialysis patients. CDC Public Health Recomm Rep. 2001;50:1–43. Alter MJ, Arduino MJ, Lyerla HC, et al. Recommendations for preventing transmission of infections among chronic hemodialysis patients. CDC Public Health Recomm Rep. 2001;50:1–43.
6.
go back to reference Dinits-Pensy M, Forrest GN, Cross AS, et al. The use of vaccines in adult patients with renal disease. Am J Kidney Dis. 2005;46:997–1011.CrossRefPubMed Dinits-Pensy M, Forrest GN, Cross AS, et al. The use of vaccines in adult patients with renal disease. Am J Kidney Dis. 2005;46:997–1011.CrossRefPubMed
7.
go back to reference Hemodialysis. Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48:2–90.CrossRef Hemodialysis. Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48:2–90.CrossRef
8.
go back to reference Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205–13.PubMed Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205–13.PubMed
9.
go back to reference National Kidney Foundation. KDOQI clinical practice guideline and clinical practice recommendations: hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access: update 2006. Am J Kidney Dis. 2006;48:1–322.CrossRef National Kidney Foundation. KDOQI clinical practice guideline and clinical practice recommendations: hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access: update 2006. Am J Kidney Dis. 2006;48:1–322.CrossRef
10.
go back to reference Port FK, Pisoni RL, Bragg-Gresham JL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004;22:175–80.CrossRefPubMed Port FK, Pisoni RL, Bragg-Gresham JL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004;22:175–80.CrossRefPubMed
11.
go back to reference HAMAGUCHI N, KOBAYASHI M, HIRABAYASHI A, et al. T lymphocyte subpopulations in patients undergoing chronic hemodialysis. Jpn J Nephrol. 1984;26:1205–12. HAMAGUCHI N, KOBAYASHI M, HIRABAYASHI A, et al. T lymphocyte subpopulations in patients undergoing chronic hemodialysis. Jpn J Nephrol. 1984;26:1205–12.
12.
go back to reference Seyahi 12N, Altiparmak MR, Ates K, et al. Current status of renal replacement therapy in Turkey: a summary of Turkish society of nephrology 2014 annual registry report. Turk Neph Dial Transpl. 2015;24:10–6.CrossRef Seyahi 12N, Altiparmak MR, Ates K, et al. Current status of renal replacement therapy in Turkey: a summary of Turkish society of nephrology 2014 annual registry report. Turk Neph Dial Transpl. 2015;24:10–6.CrossRef
13.
go back to reference Peces R, de la Torre M, Alcazar R, et al. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis. 1997;29:239–45.CrossRefPubMed Peces R, de la Torre M, Alcazar R, et al. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis. 1997;29:239–45.CrossRefPubMed
14.
go back to reference Fernandez E, Betriu MA, Gomez R. etal: Response to the hepatitis B virus vaccine in hemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transpl. 1996;11:1559–63.CrossRef Fernandez E, Betriu MA, Gomez R. etal: Response to the hepatitis B virus vaccine in hemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transpl. 1996;11:1559–63.CrossRef
15.
go back to reference Fabrizi F, Martin P, Dixit V, et al. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in endstage renal disease. Aliment Pharmacol Ther. 2004;20:1053–62.CrossRefPubMed Fabrizi F, Martin P, Dixit V, et al. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in endstage renal disease. Aliment Pharmacol Ther. 2004;20:1053–62.CrossRefPubMed
16.
go back to reference Asan A, Demirhan H, Sorgun H, et al. Factors affecting responsiveness to hepatitis B immunization in dialysis patients. Int Urol Nephrol. 2017;49:1845–50.CrossRef Asan A, Demirhan H, Sorgun H, et al. Factors affecting responsiveness to hepatitis B immunization in dialysis patients. Int Urol Nephrol. 2017;49:1845–50.CrossRef
17.
go back to reference Novarro JF, Teruel JL, Mateos ML, et al. Antibody level after hepatitis B vaccination in hemodialysis patients; influence of hepatitis C virus infection. Am J Nephrol. 1996;16:95–7.CrossRef Novarro JF, Teruel JL, Mateos ML, et al. Antibody level after hepatitis B vaccination in hemodialysis patients; influence of hepatitis C virus infection. Am J Nephrol. 1996;16:95–7.CrossRef
18.
go back to reference Pera A, Campos C, Lopez N, et al. Immunosenescence: implications for response to infection and vaccination in older people. Maturitas. 2015;82:50–5.CrossRefPubMed Pera A, Campos C, Lopez N, et al. Immunosenescence: implications for response to infection and vaccination in older people. Maturitas. 2015;82:50–5.CrossRefPubMed
20.
go back to reference Chaves SS, Daniels D, Cooper BW, et al. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection. Vaccine. 2011;29:9618–23.CrossRefPubMed Chaves SS, Daniels D, Cooper BW, et al. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection. Vaccine. 2011;29:9618–23.CrossRefPubMed
21.
go back to reference Salva I, Sharaf ED, Bazzal I. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status. J Natl Med Assoc. 2006;98:1953–7. Salva I, Sharaf ED, Bazzal I. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status. J Natl Med Assoc. 2006;98:1953–7.
22.
go back to reference Girndt M, Sester M, Sester U, et al. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2001;59:1382–9.CrossRefPubMed Girndt M, Sester M, Sester U, et al. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2001;59:1382–9.CrossRefPubMed
24.
go back to reference Sorkhi H, Roushan MRH, Al Hashemi GH, et al. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection. La Revue de Santé de la Méditerranée orientale. 2008;14:798–803. Sorkhi H, Roushan MRH, Al Hashemi GH, et al. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection. La Revue de Santé de la Méditerranée orientale. 2008;14:798–803.
25.
go back to reference Fabrizi F, Dixit V, Martin P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharm Ther. 2011;33:815–21.CrossRef Fabrizi F, Dixit V, Martin P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharm Ther. 2011;33:815–21.CrossRef
26.
go back to reference Fabrizi F, Dixit V, Martin P, et al. Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis. Kidney Blood Press R. 2012;35:504–10.CrossRef Fabrizi F, Dixit V, Martin P, et al. Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis. Kidney Blood Press R. 2012;35:504–10.CrossRef
27.
go back to reference KDOQI, National Kidney Foundation: II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47: S16–85.CrossRef KDOQI, National Kidney Foundation: II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47: S16–85.CrossRef
Metadata
Title
Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers
Authors
Halil İbrahim Erdoğdu
Eray Atalay
Gül Gürsoy
Başol Canbakan
Serkan Aktürk
Canan Yazıcı
Orhan Yücel
Sinan Mersin
Sengül Üçer
Özgür Merhametsiz
Can Öner
Merve Erat
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 4/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1676-x

Other articles of this Issue 4/2019

Clinical and Experimental Nephrology 4/2019 Go to the issue